Avanlee Care, a company focusing on elderly care coordination, announced it is integrating Mark Cuban Cost Plus Drug Company’s (MCCPDC) offerings into its Ava app to provide affordable medications to caregivers and their loved ones.
Avanlee launched its app in 2021, which intends to improve existing eldercare technology by combining necessary tools and services in one location for unpaid family...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for chronic obstructive pulmonary disease patients in the U.S.
COPD is a chronic inflammatory lung disease that obstructs airflow from the lungs and causes breathing problems. Tiotropium Bromide treats...
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced that it's working with Coherus Biosciences to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price.
Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s...
Seattle-based Zócalo Health, a virtual healthcare service for Latino patients, is collaborating with Mark Cuban Cost Plus Drug Company (MCCPDC) to expand its members' access to lower-cost prescription medication.
Launched in 2021, Zócalo offers Latino patients in Texas and California virtual primary care services and mental health support.
The company also offers a virtual urgent care clinic...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with diabetes and chronic disease management company Diathrive Health to provide lower-cost prescription medication and diabetes testing supplies to Diathrive's members.
Diathrive Health offers individuals and employers personalized coaching via live messaging and video chat, as well as care plans, articles and videos to help manage...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with cancer care support company OncoPower to offer prescription drugs at a decreased cost via a platform dubbed Medication Savings Suite.
The suite will be integrated within OncoPower's Pill Reminder Tool, which will alert patients of cheaper generic medication options available through MCCPDC when patients log a new medication into the...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced a partnership with pharmacy benefit manager EmsanaRx to allow employers and employees access to lower-cost prescription drugs via a new platform called EmsanaRx Plus.
EmsanaRx Plus is a supplemental discount drug platform designed specifically for employers. It utilizes EmsanaRx's ability to integrate with employer-sponsored drug benefits, and...
The Mark Cuban Cost Plus Drug Company is jumping into the online pharmacy sector, launching a new digital marketplace. The company pitches the digital pharmacy as a way to help consumers find medications for less money.
In November, the company unveiled its pharmacy benefit manager (PBM) operation, which the company says lets them cut out the "middlemen" and price markups in their online...
Zephyr's BioPatch is a likely candidate for the NBA D-League's new tracking initiative.
The National Basketball Association will become the first major American sports league to equip its players with wearable health and activity monitors -- not just during practices, but during actual games as well. The NBA's Development League (or D-League) has already begun to outfit players on D-League...
_1.jpg?itok=TSQSsVDE "Mark Cuban, cofounder of Mark Cuban Cost Plus Drug Company")
